Quantitative Analysis of Favipiravir by HPLC: Development and Validation

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="2">Favipiravir conc. (mg/ml)</td><td class="align_center">Avg</td><td class="align_center">Avg</td><td class="align_center">Avg</td><td class="align_center" rowspan="2">Interference (%)</td></tr><tr class="thead"><td class="align_center">ABS<sub>Placebo</sub></td><td class="align_center">ABS<sub>St</sub></td><td class="align_center">ABS<sub>Sa</sub></td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">0.50</td><td class="align_center">0</td><td class="align_center">36.804</td><td class="align_center">36.94</td><td class="align_center">0.00</td></tr><tr><td class="align_left">Acceptance criteria</td><td class="align_center" colspan="4">NMT 2%</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Interference data and results for favipiravir.</div>

International Journal of Analytical Chemistry

tab2

Table 2

Table 2: Quantitative Analysis of Favipiravir by HPLC: Development and Validation 